Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Public Health Dispatch: Manufacturer's Recall of Rapid Assay Kits Based
on False Positive Cryptosporidium Antigen Tests --- Wisconsin, 2001--2002
The Wisconsin Division of Public Health and the Wisconsin State Laboratory of Hygiene (WSLH) reported that a
recent cluster of cryptosporidiosis cases in a three-county area in southeastern Wisconsin was the result of false-positive tests.
During December 1, 2001--February 1, 2002, approximately 30 cases of cryptosporidiosis were diagnosed at a laboratory
in southeastern Wisconsin using the Becton, Dickinson, and Company (Franklin Lakes, New Jersey)
ColorPACTMCryptosporidium/Giardia rapid assay (lot number 219370, expiration date 2002-06-05). Seventeen stool specimens,
which
were collected from 11 patients and tested positive by the rapid assay, were re-evaluated at WSLH. Six of these
stool specimens were in EcoFix (Meridian Bioscience Inc., Cincinnati, Ohio), eight were in Cary-Blair transport media, and
three were formalin fixed. All 17 specimens tested negative for
Cryptosporidium at WSLH using the hot safranin stain
and MeriFluor (Meridian Bioscience Inc., Cincinnati, Ohio)
Cryptosporidium/Giardia direct fluorescent antibody kit
with concentrated specimens.
For comparison, WSLH repeated the rapid assay tests of the specimens using Becton, Dickinson, and
Company ColorPACTMCryptosporidium/Giardia rapid assay from the same lot used at the southeastern Wisconsin laboratory.
Eleven (65%) of the 17 stool specimens were positive on repeat testing, including five (83%) specimens in EcoFix, four (50%)
of specimens in Cary-Blair transport media, and two (67%) of the formalin-fixed specimens. The
ColorPACTM kits also were used to test four known
Cryptosporidium negative stool specimens, and two of these tests were positive. Becton,
Dickinson, and Company has voluntarily recalled this lot from laboratories.
Reported by: T Haupt, MS, JP Davis, MD, Wisconsin Div of Public Health; D Warshauer, PhD, Wisconsin State Laboratory of Hygiene.
M Beach, PhD, S Johnson, MS, Div of Parasitic Diseases, National Center for Infectious Diseases; D Croft, MD, EIS Officer,
CDC.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
